CSPAN2 Key Capitol Hill Hearings June 8, 2016
Found in this overlap with drugs with potential legitimate therapeutic use. For this Lateral Group of compound requirements using schedule one may act as a disincentive. To echo michael botticelli, we believe by performing significant review we can balance the risks posed by illicit risk of these compounds well preserving the need to develop new understanding. Theyre committed to working with other partners on science in this area to understand and enhance the timely and appropriate assessment of these. We hope that as the Committee Explores ways of addressing the problem we will continue to g...